|
1
|
Getinet M, Gelaw B, Sisay A, Mahmoud EA
and Assefa A: Prevalence and predictors of Pap smear cervical
epithelial cell abnormality among HIV-positive and negative women
attending gynecological examination in cervical cancer screening
center at Debre Markos referral hospital, East Gojjam, Northwest
Ethiopia. BMC Clin Pathol. 15(16)2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chigira M, Noda K and Watanabe H: Autonomy
in tumor cell proliferation. Med Hypotheses. 32:249–54.
1990.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Berek JS: Berek and Novak's gynecology.
Cervical and vaginal cancer. 14th edition. Lippincott Williams and
Wilkins, Philadelphia, PA, pp561-579, 2007.
|
|
4
|
Gebremariam TT: Human papillomavirus
related cervical cancer and anticipated vaccination challenges in
Ethiopia. Int J Health Sci (Qassim). 10:137–143. 2016.PubMed/NCBI
|
|
5
|
Ruland R, Prugger C, Schiffer R, Regidor M
and Lellé R: Prevalence of human papilloma virus infection in women
in rural Ethiopia. Eur J Epidemiol. 21:727–729. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gessesse Z, Tadesse Z, Alemayehu M, Hiruye
A, Getachew Y, Derbew M, Mariam DH, Mammo D, Eva K, Yebyo H and
Michael HG: Determinant factors of visual inspection with acetic
acid (VIA) positive lesions among HIV positive women in Mekelle
Hospital, Northern Ethiopia: A case control study. Ethiop Med J. 53
(Supp 2):S17–S24. 2015.PubMed/NCBI
|
|
7
|
Santesso N, Mustafa RA, Schünemann HJ,
Arbyn M, Blumenthal PD, Cain J, Chirenje M, Denny L, De Vuyst H,
Eckert LO, et al: World Health Organization Guidelines for
treatment of cervical intraepithelial neoplasia 2-3 and
screen-and-treat strategies to prevent cervical cancer. Int J
Gynaecol Obstet. 132:252–258. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Teka T, Kote M, Kejela G and Getachew T:
Magnitude and factors associated with precervical cancer among
screened women in Southern Ethiopia. Adv Public Health. 2019:1–8.
2019.
|
|
9
|
Leyh-Bannurah SR, Prugger C, de Koning MN,
Goette H and Lellé RJ: Cervical human papillomavirus prevalence and
genotype distribution among hybrid capture 2 positive women 15 to
64 years of age in the Gurage zone, rural Ethiopia. Infect Agent
Cancer. 9(33)2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Federal Democratic Republic of Ethiopia
Ministry of Health: Guideline for Cervical Cancer Prevention and
Control in Ethiopia. FMOH, Addis Ababa, 2015. https://www.medbox.org/document/guideline-for-cervical-cancer-prevention-and-control-in-ethiopia.
|
|
11
|
de Sanjosé S, Serrano B, Castellsagué X,
Brotons M, Muñoz J, Bruni L and Bosch FX: Human papillomavirus
(HPV) and related cancers in the global Alliance for vaccines and
immunization (GAVI) countries: A WHO/ICO HPV information Centre
report. Vaccine. 30 (Suppl 4):D1–D83, vi. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
World Health Organization (WHO):
Comprehensive cervical cancer control: A guide to essential
practice. 2nd edition. WHO, Geneva, 2014.
|
|
13
|
Arbyn M, Weiderpass E, Bruni L, de Sanjose
S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and
mortality of cervical cancer in 2018: A worldwide analysis. Lancet
Glob Health. 8:e191–e203. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Koutsky LA, Ault KA, Wheeler CM, Brown DR,
Barr E, Alvarez FB, Chiacchierini LM and Jansen KU: Proof of
Principle Study Investigators. A controlled trial of a human
papillomavirus type 16 vaccine. N Engl J Med. 347:1645–1651.
2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gillison ML, Chaturvedi AK and Lowy DR:
HPV prophylactic vaccines and the potential prevention of
noncervical cancers in both men and women. Cancer. 113 (10
Suppl):S3036–S3046. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Quinlan JD: Human papillomavirus:
Screening, testing, and prevention. Am Fam Physician. 104:152–159.
2021.PubMed/NCBI
|
|
17
|
González-Rodríguez JC, Cruz-Valdez A and
Madrid-Marina V: Cervical cancer prevention by vaccination: Review.
Front Oncol. 14(1386167)2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Temesgen MM, Alemu T, Shiferaw B, Legesse
S, Zeru T, Haile M and Gelanew T: Prevalence of oncogenic human
papillomavirus (HPV 16/18) infection, cervical lesions and its
associated factors among women aged 21-49 years in Amhara region,
Northern Ethiopia. PLoS One. 16(e0248949)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Elfil M and Negida A: Sampling methods in
clinical research; an educational review. Emerg (Tehran).
5(e52)2017.PubMed/NCBI
|
|
20
|
Temesgen K, Dilnessa T, Workie A and Abate
M: Proportions of pre-cancerous cervical lesions and its associated
factors among women clients in the age group of 30-49yrs in
gynecology ward of dessie referral hospital and FGAE, North-East
Ethiopia, 2016. J Cancer Tumor Int. 9:1–15. 2019.
|
|
21
|
Kahesa C, Kjaer SK, Ngoma T, Mwaiselage J,
Dartell M, Iftner T and Rasch V: Risk factors for VIA positivity
and determinants of screening attendances in Dar es Salaam,
Tanzania. BMC Public Health. 12(1055)2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tao L, Han L, Li X, Gao Q, Pan L, Wu L,
Luo Y, Wang W, Zheng Z and Guo X: Prevalence and risk factors for
cervical neoplasia: A cervical cancer screening program in Beijing.
BMC Public Health. 14(1185)2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Getinet M, Taye M, Ayinalem A and Gitie M:
Precancerous lesions of the cervix and associated factors among
women of East Gojjam, Northwest Ethiopia, 2020. Cancer Manag Res.
13:9401–9410. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Federal Democratic Republic of Ethiopia
Ministry of Health (FMOH): Health Sector Development Programme IV
2010/11-2014/15, 2010.
|
|
25
|
Chan CK, Aimagambetova G, Ukybassova T,
Kongrtay K and Azizan A: Human papillomavirus infection and
cervical cancer: Epidemiology, screening, and vaccination-review of
current perspectives. J Oncol. 2019(3257939)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Salih MM, Safi ME, Hart K, Tobi K and Adam
I: Genotypes of human papilloma virus in Sudanese women with
cervical pathology. Infect Agent Cancer. 5(26)2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Edna Omar V, Orvalho A, Nália I, Kaliff M,
Lillsunde-Larsson G, Ramqvist T, Nilsson C, Falk K, Nafissa O,
Ilesh Vindorai J and Andersson S: Human papillomavirus prevalence
and genotype distribution among young women and men in Maputo city,
Mozambique. BMJ Open. 7(e015653)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bekele A, Baay M, Mekonnen Z, Suleman S
and Chatterjee S: Human papillomavirus type distribution among
women with cervical pathology-a study over 4 years at Jimma
Hospital, southwest Ethiopia. Trop Med Int Health. 15:890–893.
2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ameya G and Yerakly F: Characteristics of
cervical disease among symptomatic women with histopathological
sample at Hawassa University referral hospital, Southern Ethiopia.
BMC Womens Health. 17(91)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Derbie A, Mekonnen D, Mezgebu Y and
Biadglegne F: Cervical lesion detection using visual inspection
with acetic acid and associated factors among Ethiopian women.
Ethiop Med J. 57:117–124. 2019.
|
|
31
|
World Health Organization (WHO):
International Agency for Research on Cancer & African
Population and Health Research Center. Prevention of cervical
cancer through screening using visual inspection with acetic acid
(VIA) and treatment with cryotherapy. A demonstration project in
six African countries: Malawi, Madagascar, Nigeria, Uganda, the
United Republic of Tanzania, and Zambia. WHO, Geneva, 2012.
|
|
32
|
Belayneh T, Mitiku H and Weldegebreal F:
Precancerous cervical lesion and associated factors among
HIV-infected women on ART in Amhara Regional State, Ethiopia: A
hospital-based cross-sectional study. Int J Health Sci (Qassim).
13:4–9. 2019.PubMed/NCBI
|
|
33
|
Teame H, Addissie A, Ayele W, Hirpa S,
Gebremariam A, Gebreheat G and Jemal A: Factors associated with
cervical precancerous lesions among women screened for cervical
cancer in Addis Ababa, Ethiopia: A case control study. PLoS One.
13(e0191506)2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Bezabih M, Tessema F, Sengi H and Deribew
A: Risk factors associated with invasive cervical carcinoma among
women attending Jimma University Specialized Hospital, Southwest
Ethiopia: A case control study. Ethiop J Health Sci. 25:345–352.
2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Beyene TT, Akibu M, Bekele H and Seyoum W:
Determinants of precancerous cervical lesion among women screened
for cervical cancer in south Ethiopia: A case-control study. Res
Sq, 2019.
|
|
36
|
Ansa M and Mekonnen T: Prevalence of via
positive cervical lesions and determinant factors among women
attending regular gynecology outpatient department (rgopd) at saint
paul's hospital millennium medical college (sphmmc). Ethiop J
Reprod Health. 10:20–30. 2018.
|
|
37
|
Kassa LS, Dile WM, Zenebe GK and Berta AM:
Precancerous lesions of cervix among women infected with HIV in
Referral Hospitals of Amhara Region, Northwest Ethiopia: A cross
sectional study. Afr Health Sci. 19:1695–1704. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Utoo B, Utoo P, Ngwan S, Anzaku S and
Daniel M: Cervical intraepithelial neoplasia: Prevalence, risk
factors, and utilization of screening services among an urban
population in Nigeria. Trop J Obstet Gynaecol. 33(279)2016.
|
|
39
|
Bruni L, Albero G, Serrano B, Mena M,
Collado JJ, Gómez D, Muñoz J, Bosch FX and de Sanjosé S: Human
papillomavirus and related diseases in Ethiopia. Summary Report
ICO/IARC Information Centre on HPVand Cancer (HPV Information
Centre), 2023.
|
|
40
|
Tesfa A: Combating cervical cancer in
Ethiopia. Pathfinder International/Ethiopia, 2010.
|
|
41
|
Izudi J, Adrawa N and Amongin D:
Precancerous cervix in human immunodeficiency virus infected women
thirty years old and above in Northern Uganda. J Oncol.
2016(5473681)2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chichareon S, Herrero R, Muñoz N, Bosch
FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer
CJ and Walboomers JM: Risk factors for cervical cancer in Thailand:
A case-control study. J Natl Cancer Inst. 90:50–57. 1998.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Plisko O, Zodzika J, Rezeberga D,
Jermakova I, Kroica J, Sivina D, Kunicina D and Eglite L:
Associations between sexually transmitted infections and cervical
precancerous lesions in Latvian women. Eur J Obstet Gynecol Reprod
Biol. 234(E153)2019.
|
|
44
|
Temmerman M, Tyndall MW, Kidula N, Claeys
P, Muchiri L and Quint W: Risk factors for human papillomavirus and
cervical precancerous lesions, and the role of concurrent HIV-1
infection. Int J Gynaecol Obstet. 65:171–181. 1999.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sahasrabuddhe VV, Mwanahamuntu MH, Vermund
SH, Huh WK, Lyon MD, Stringer JSA and Parham GP: Prevalence and
distribution of HPV genotypes among HIV-infected women in Zambia.
Br J Cancer. 96:1480–1483. 2007.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Mukanyangezi MF, Rugwizangoga B, Manzi O,
Rulisa S, Hellstrand K, Tobin G, Martner A, Bienvenu E and Giglio
D: Persistence rate of cervical human papillomavirus infections and
abnormal cytology in Rwanda. HIV Med. 20:485–495. 2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chambuso RS, Shadrack S, Lidenge SJ,
Mwakibete N and Medeiros RM: Influence of HIV/AIDS on cervical
cancer: A retrospective study from Tanzania. J Global Oncol.
3:72–78. 2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Moodley JR, Hoffman M, Carrara H, Allan
BR, Cooper DD, Rosenberg L, Denny LE, Shapiro S and Williamson AL:
HIV and pre-neoplastic and neoplastic lesions of the cervix in
South Africa: A case-control study. BMC Cancer.
6(135)2006.PubMed/NCBI View Article : Google Scholar
|
|
49
|
McFarlane-Anderson N, Bazuaye PE, Jackson
MD, Smikle M and Fletcher HM: Cervical dysplasia and cancer and the
use of hormonal contraceptives in Jamaican women. BMC Womens
Health. 8(9)2008.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Bosch FX, Manos MM, Muñoz N, Sherman M,
Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV:
Prevalence of human papillomavirus in cervical cancer: A worldwide
perspective. International biological study on cervical cancer
(IBSCC) Study Group. J Natl Cancer Inst. 87:796–802.
1995.PubMed/NCBI View Article : Google Scholar
|
